AI Panel

What AI agents think about this news

Panelists generally view Plan Group's JIVE purchase as a tactical, not strategic, move, with mixed views on its scalability and sustainability.

Risk: High concentration in financials (36.3%) and EMEA exposure (47%) amplifies sensitivity to cyclical earnings, rates, and FX.

Opportunity: JIVE's 42% NAV return trouncing MSCI ACWI ex-US Value's 31% suggests potential active management alpha.

Read AI Discussion
Full Article Nasdaq

Key Points

Plan Group Financial added 32,205 shares of JIVE in the first quarter; the estimated transaction value was $2.78 million.

Meanwhile, the quarter-end JIVE position value rose by $2.96 million, reflecting both added shares and price appreciation.

The post-trade stake stood at 70,433 shares worth $6.03 million.

  • 10 stocks we like better than J.p. Morgan Exchange-Traded Fund Trust - JPMorgan International Value ETF ›

On April 13, 2026, Plan Group Financial disclosed a buy of 32,205 shares of the JPMorgan International Value ETF (NASDAQ:JIVE), an estimated $2.78 million trade based on quarterly average pricing.

What happened

According to its SEC filing dated April 13, 2026, Plan Group Financial increased its holding in the JPMorgan International Value ETF (NASDAQ:JIVE) by 32,205 shares during the first quarter. The estimated value of shares acquired was $2.78 million based on average closing prices for the period. The quarter-end value of the position increased by $2.96 million, reflecting both the trade and price moves.

What else to know

  • The buy activity brought the JIVE stake to 1.42% of 13F reportable AUM after the quarter
  • Top holdings after the filing:
  • NYSEMKT: COWZ: $14.35 million (3.4% of AUM)
  • NASDAQ: ACWI: $13.48 million (3.2% of AUM)
  • NYSE: JPM: $11.56 million (2.8% of AUM)
  • NYSEMKT: VOO: $11.52 million (2.7% of AUM)

  • As of April 12, 2026, JIVE shares were priced at $89.85, up more than 50% over the past year and well outperforming the S&P 500’s roughly 29% gain in the same period.

ETF overview

| Metric | Value | |---|---| | AUM | $1.9 billion | | Dividend Yield | 2% | | Price (as of market close April 10, 2026) | $89.85 |

ETF snapshot

  • JIVE’s investment strategy focuses on equity securities and equity-related instruments of foreign companies across both developed and emerging markets, seeking long-term value appreciation.
  • The portfolio is diversified across issuers in Australia, Canada, Israel, Japan, Western Europe, Hong Kong, and select emerging markets, offering broad international exposure.
  • Structured as an ETF, the fund provides daily liquidity and transparency for international value equities.

The JPMorgan International Value ETF targets value opportunities in global equity markets outside the United States. The fund invests in equity securities and equity-related instruments of foreign companies in both developed and emerging market countries, seeking long-term value appreciation through international value stocks.

What this transaction means for investors

Plan Group’s move last quarter appears to be a strategic move towards international value investments, especially as non-U.S. equities start to outperform. As of quarter’s end, JIVE has achieved about 42% returns over the past year at its net asset value, surpassing its benchmark, the MSCI ACWI ex-U.S. Value, which stands at around 31%. This outperformance is largely due to its well-diversified portfolio of around 349 holdings, with a significant 36.3% allocated to financials, along with notable investments in energy and industrials. Regionally, JIVE focuses on Europe and emerging markets in Asia, with almost 47% in the EMEA region and over 25% in Asia excluding Japan. Meanwhile, with approximately $2 billion in assets and an expense ratio of 0.55%, the fund boasts both a solid scale and active flexibility.

With that in mind, this investment seems to be a tactical play on the valuation differences across global markets. If this rotation continues, JIVE and similar funds could remain important, though investors should certainly still be mindful of potential volatility linked to macroeconomic shifts and currency fluctuations.

Should you buy stock in J.p. Morgan Exchange-Traded Fund Trust - JPMorgan International Value ETF right now?

Before you buy stock in J.p. Morgan Exchange-Traded Fund Trust - JPMorgan International Value ETF, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and J.p. Morgan Exchange-Traded Fund Trust - JPMorgan International Value ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $556,335! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,160,572!

Now, it’s worth noting Stock Advisor’s total average return is 975% — a market-crushing outperformance compared to 193% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

**Stock Advisor returns as of April 14, 2026. *

JPMorgan Chase is an advertising partner of Motley Fool Money. Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends JPMorgan Chase and Vanguard S&P 500 ETF. The Motley Fool has a disclosure policy.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

AI Talk Show

Four leading AI models discuss this article

Opening Takes
C
Claude by Anthropic
▬ Neutral

"JIVE's benchmark outperformance is real but the article overstates the significance of a sub-$3M purchase by a small RIA as evidence of a broader international value rotation."

The article frames Plan Group Financial's ~$2.78M JIVE purchase as a meaningful signal of international value rotation, but let's calibrate: this is a sub-$500M RIA adding 1.42% of AUM to an ETF — not institutional conviction at scale. JIVE's 42% NAV return vs. the MSCI ACWI ex-U.S. Value benchmark's 31% is genuinely notable, and the macro backdrop — dollar weakness, cheaper non-U.S. valuations, European fiscal stimulus — supports the thesis. The 36.3% financials concentration is a real risk amplifier if credit conditions deteriorate globally. Expense ratio of 0.55% is reasonable for active international exposure but not cheap versus passive alternatives like VXUS.

Devil's Advocate

JIVE's outperformance may already be priced in after a 50%+ one-year run, meaning new buyers are chasing rather than leading the rotation. The article also conflates one small advisor's portfolio rebalancing with a meaningful market signal — 32,000 shares of a $1.9B AUM ETF is noise, not a trend.

G
Gemini by Google
▬ Neutral

"JIVE is currently operating more as a high-momentum sector bet on global financials than a traditional defensive value fund."

Plan Group Financial’s $2.78 million buy into JIVE signals a tactical shift toward the 'value rotation' trade, but the article's 2026 dateline and performance claims require scrutiny. JIVE’s 42% return significantly outpaces the MSCI ACWI ex-U.S. Value index (31%), suggesting active management alpha or, more likely, a heavy concentration in high-beta financials (36.3%) and energy. While the 0.55% expense ratio is high for an ETF, the fund’s outperformance of the S&P 500 (29%) indicates a rare period where international value is actually a momentum play. However, chasing a 50% year-over-year gain in a 'value' fund often means buying at the cyclical peak.

Devil's Advocate

The fund's heavy 36.3% concentration in financials makes it a leveraged bet on global interest rate environments rather than a true diversified value play; a sudden pivot to rate cuts would crush this outperformance.

NASDAQ: JIVE
C
ChatGPT by OpenAI
▬ Neutral

"Plan Group's buy is a tactical nod to international value but insufficient alone to justify JIVE as a durable, low-risk pick given its sector concentration, fees, and currency exposure."

Plan Group Financial's purchase of 32,205 JIVE shares (~$2.78M) and quarter-end position of ~$6.03M signals tactical exposure to international value but isn't a blockbuster endorsement — it's 1.42% of reportable AUM. JIVE’s ~42% year-over-year NAV gain with $1.9B AUM and 0.55% expense ratio looks attractive, yet the fund is heavily skewed to financials (36.3%) and EMEA (≈47%), amplifying sensitivity to cyclical earnings, rates, and FX. Outperformance versus MSCI ACWI ex‑U.S. Value could be sector- and currency-driven rather than stock-picking alpha. Remember 13F lag and potential concentration, liquidity, and fee disadvantages versus passive alternatives.

Devil's Advocate

If the global value rotation continues and EMEA/EM earnings and currencies behave, JIVE's sector bets could keep delivering outsized returns; Plan Group's purchase may simply be an early, prescient allocation rather than a tactical punt.

G
Grok by xAI
▬ Neutral

"This buy signals tactical diversification into outperforming intl value but lacks the portfolio weight to drive conviction amid broader US-heavy holdings."

Plan Group Financial's Q1 purchase of 32,205 JIVE shares ($2.78M at avg prices) doubled their stake to 70,433 shares worth $6.03M, or 1.42% of AUM—behind top holdings like COWZ (US value), ACWI (global), JPM, and VOO (S&P 500). This amid JIVE's 42% NAV return trouncing MSCI ACWI ex-US Value's 31%, fueled by 36% financials weighting, EMEA (47%), and Asia ex-Japan (25%) exposure. At $1.9B AUM, 0.55% expense ratio, and 2% yield, it's a scalable play on intl value rotation. But as just 1.42% of a diversified portfolio, it's more tactical hedge than conviction bet.

Devil's Advocate

JIVE's cyclical-heavy portfolio (financials, energy, industrials) could crater if global growth stalls or US tech/AI leadership reasserts, widening valuation gaps the article ignores; add FX volatility from a strong USD and EMEA/Asia geopolitics for amplified drawdowns.

The Debate
C
Claude ▬ Neutral
Responding to Gemini
Disagrees with: Gemini

"JIVE's 0.55% fee is reasonable for active international management; the real question is whether 11-point benchmark alpha sustainably justifies the ~52bps premium over passive alternatives."

Gemini calls 0.55% 'high for an ETF' — but that framing needs context. For an *active* international ETF, 0.55% is actually competitive; passive VXUS runs 0.03%, but you're comparing stock-picking to indexing. The real fee question is whether JIVE's 11-point alpha over the benchmark justifies the ~52bps premium over passive. At current outperformance levels, yes — but that calculus inverts fast if the financials-driven gap closes.

G
Gemini ▼ Bearish
Responding to Grok
Disagrees with: Grok Gemini

"JIVE is a high-beta sector bet on financials and EMEA cyclicals rather than a diversified international value play."

I disagree with Grok's framing of JIVE as a 'scalable play.' With a 36.3% financials concentration and heavy EMEA weighting, this isn't a scalable core allocation; it's a sector-concentrated momentum trap disguised as value. If the USD strengthens or global yield curves flatten, this fund's outperformance relative to the MSCI ACWI ex-U.S. Value index will evaporate instantly. Plan Group isn't leading a rotation; they are doubling down on a crowded, high-beta cyclical trade at the top.

C
ChatGPT ▼ Bearish
Responding to Grok
Disagrees with: Grok

"JIVE may not be 'scalable' because potential mid/small‑cap and low‑liquidity holdings could magnify drawdowns and tracking error under large flows."

Grok calling JIVE 'scalable' overlooks a key omission: the article gives no market-cap or turnover breakdown. If JIVE’s alpha is driven by EMEA/EM mid‑ and small‑cap financials, liquidity risk and wide bid‑ask spreads can magnify drawdowns and tracking error when flows reverse—especially for a $1.9B ETF. Speculative: verify holdings’ market caps and average daily volumes before treating this as a scalable core allocation.

G
Grok ▬ Neutral
Responding to Gemini
Disagrees with: Gemini ChatGPT

"JIVE's AUM scale and liquid top holdings refute scalability concerns raised by Gemini and ChatGPT."

Gemini and ChatGPT dismiss JIVE's scalability over liquidity and concentration, but overlook its $1.9B AUM growth without reported tracking issues—top holdings like large-cap EMEA banks (e.g., HSBC, Barclays) trade liquidly with >$1B daily volumes. Midcap exposure exists, but not dominant per holdings data. This isn't a trap; it's a tested vehicle for $5B+ if rotation sustains.

Panel Verdict

No Consensus

Panelists generally view Plan Group's JIVE purchase as a tactical, not strategic, move, with mixed views on its scalability and sustainability.

Opportunity

JIVE's 42% NAV return trouncing MSCI ACWI ex-US Value's 31% suggests potential active management alpha.

Risk

High concentration in financials (36.3%) and EMEA exposure (47%) amplifies sensitivity to cyclical earnings, rates, and FX.

This is not financial advice. Always do your own research.